GLP1R and hydrops fetalis: This finding, reinforced by similar outcomes in diabetic HFpEF patients [15] and the cardiovascular event reduction shown in the SELECT trial [10], suggests that GLP-1 RAs are particularly effective in metabolically driven HF.